Autoantibody detection using indirect immunofluorescence on HEp-2 cells.

Area of Science:

• Clinical immunology
• Autoimmune disease diagnostics
• Laboratory medicine

Background:

• Indirect immunofluorescence (IIF) on HEp-2 cells is crucial for diagnosing autoimmune diseases.
• Variability in IIF test results between laboratories hinders accurate diagnosis and monitoring.
• Lack of standardization and subjective interpretation contribute to diagnostic discrepancies.

Purpose of the Study:

• To establish standardized protocols for processing and interpreting HEp-2 cell indirect immunofluorescence tests.
• To improve the reliability and consistency of non-organ-specific antibody detection, particularly antinuclear antibodies (ANAs).
• To enhance the diagnostic accuracy and patient care in autoimmune diseases through standardization.

Main Methods:

• Formulating recommendations for diagnostic test requirements and laboratory procedures.
• Defining standardized evaluation and interpretation guidelines for HEp-2 cell immunofluorescence.
• Implementing initial screening at 1:80 serum dilution and considering titers ≥1:160 as positive.

Main Results:

• Proposed standardized processing and interpretation of HEp-2 cell indirect immunofluorescence tests.
• Emphasized the importance of experienced diagnosticians and tentative clinical diagnosis.
• Recommended initial screening at 1:80 dilution, positive results from 1:160, internal quality control, and standardized interpretation.

Conclusions:

• Standardized HEp-2 cell testing protocols are essential for reliable ANA detection.
• Improved standardization will lead to more accurate autoimmune disease diagnosis and patient management.
• These recommendations aim to enhance diagnostic test quality and patient outcomes, aligning with EASI goals.